Committed to providing exceptional care and continued support to patients, families and caregivers.

Menu

NCT01806064

Disease Type: Genitourinary
Status: Open

Trial Information

A Randomized, Phase 2 trial of Axtinib and TRC105 versus Axtinib alone (including a lead- in phase 1b portion) in patients with advanced or metastatic renal cell carcinoma

Click here for more information

This trial is available at:

Midwest Cancer Center – Legacy
17201 Wright Street, Suite 200, Omaha, NE 68130
Phone: 402-334-4773
Fax: 402-330-7463

For more information, please contact: